14-day Premium Trial Subscription Try For FreeTry Free
$64.55
+0.84 (+1.32%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 23, 2024 Buy 15 000 Pickering Grant Common Stock
Apr 23, 2024 Sell 15 000 Pickering Grant Common Stock
Apr 23, 2024 Sell 15 000 Pickering Grant Stock Option (Right to Buy)
Apr 18, 2024 Sell 8 000 Guggenhime Andrew Stock Option (right to buy)
Apr 18, 2024 Buy 8 000 Guggenhime Andrew Common Stock
Apr 18, 2024 Sell 7 624 Guggenhime Andrew Common Stock
Apr 18, 2024 Sell 376 Guggenhime Andrew Common Stock
Apr 17, 2024 Buy 3 551 Wassil Jim Common Stock
Apr 17, 2024 Sell 3 551 Wassil Jim Stock Option (right to buy)
Apr 01, 2024 Sell 1 667 Eydelman Mikhail Stock Option (right to buy)
Apr 01, 2024 Buy 1 667 Eydelman Mikhail Common Stock
Apr 01, 2024 Sell 1 397 Eydelman Mikhail Common Stock
Apr 01, 2024 Sell 270 Eydelman Mikhail Common Stock
Apr 01, 2024 Sell 2 323 Wassil Jim Common Stock
Apr 01, 2024 Sell 677 Wassil Jim Common Stock
Apr 01, 2024 Sell 890 Pickering Grant Common Stock
Apr 01, 2024 Sell 984 Pickering Grant Common Stock
Apr 01, 2024 Sell 415 Pickering Grant Common Stock
Apr 01, 2024 Sell 324 Pickering Grant Common Stock
Apr 01, 2024 Sell 3 Pickering Grant Common Stock
Mar 25, 2024 Buy 15 000 Pickering Grant Common Stock
Mar 25, 2024 Sell 13 450 Pickering Grant Common Stock
Mar 25, 2024 Sell 1 550 Pickering Grant Common Stock
Mar 25, 2024 Sell 15 000 Pickering Grant Stock Option (Right to Buy)
Mar 18, 2024 Sell 8 000 Guggenhime Andrew Stock Option (right to buy)
Mar 18, 2024 Buy 8 000 Guggenhime Andrew Common Stock
Mar 18, 2024 Sell 7 764 Guggenhime Andrew Common Stock
Mar 18, 2024 Sell 236 Guggenhime Andrew Common Stock
Mar 15, 2024 Buy 4 099 Wassil Jim Common Stock
Mar 15, 2024 Sell 1 484 Wassil Jim Common Stock
Mar 11, 2024 Buy 65 000 Pickering Grant Common Stock
Mar 11, 2024 Sell 65 000 Pickering Grant Stock Option (right to buy)
Mar 02, 2024 Sell 2 178 Wassil Jim Common Stock
Mar 02, 2024 Sell 324 Cowan Elvia Common Stock
Mar 02, 2024 Sell 613 Eydelman Mikhail Common Stock
Mar 02, 2024 Sell 3 795 Guggenhime Andrew Common Stock
Mar 02, 2024 Sell 7 967 Pickering Grant Common Stock
Mar 01, 2024 Sell 1 017 Wassil Jim Common Stock
Mar 01, 2024 Sell 1 220 Wassil Jim Common Stock
Mar 01, 2024 Sell 763 Wassil Jim Common Stock
Mar 01, 2024 Sell 11 000 Cowan Elvia Stock Option (right to buy)
Mar 01, 2024 Buy 11 000 Cowan Elvia Common Stock
Mar 01, 2024 Sell 2 322 Cowan Elvia Common Stock
Mar 01, 2024 Sell 4 455 Cowan Elvia Common Stock
Mar 01, 2024 Sell 4 901 Cowan Elvia Common Stock
Mar 01, 2024 Sell 1 667 Eydelman Mikhail Stock Option (right to buy)
Mar 01, 2024 Buy 1 667 Eydelman Mikhail Common Stock
Mar 01, 2024 Sell 519 Eydelman Mikhail Common Stock
Mar 01, 2024 Sell 703 Eydelman Mikhail Common Stock
Mar 01, 2024 Sell 445 Eydelman Mikhail Common Stock
Mar 01, 2024 Sell 366 Pickering Grant Common Stock
Mar 01, 2024 Sell 506 Pickering Grant Common Stock
Mar 01, 2024 Sell 439 Pickering Grant Common Stock
Mar 01, 2024 Sell 591 Pickering Grant Common Stock
Mar 01, 2024 Sell 363 Pickering Grant Common Stock
Mar 01, 2024 Sell 351 Pickering Grant Common Stock
Feb 29, 2024 Buy 20 000 Wassil Jim Common Stock
Feb 29, 2024 Buy 90 000 Wassil Jim Stock Option (right to buy)
Feb 29, 2024 Buy 25 000 Cowan Elvia Stock Option (right to buy)
Feb 29, 2024 Buy 5 400 Cowan Elvia Common Stock
Feb 29, 2024 Buy 50 000 Eydelman Mikhail Stock Option (right to buy)
Feb 29, 2024 Buy 10 500 Eydelman Mikhail Common Stock
Feb 29, 2024 Buy 20 000 Guggenhime Andrew Common Stock
Feb 29, 2024 Buy 90 000 Guggenhime Andrew Stock Option (right to buy)
Feb 29, 2024 Buy 45 000 Pickering Grant Common Stock
Feb 29, 2024 Buy 205 000 Pickering Grant Stock Option (right to buy)
Feb 26, 2024 Buy 30 000 Pickering Grant Common Stock
Feb 26, 2024 Sell 30 000 Pickering Grant Common Stock
Feb 26, 2024 Sell 30 000 Pickering Grant Stock Option (Right to Buy)
Feb 23, 2024 Buy 15 000 Pickering Grant Common Stock
Feb 23, 2024 Sell 2 356 Pickering Grant Common Stock
Feb 23, 2024 Sell 6 980 Pickering Grant Common Stock
Feb 23, 2024 Sell 5 545 Pickering Grant Common Stock
Feb 23, 2024 Sell 119 Pickering Grant Common Stock
Feb 23, 2024 Sell 15 000 Pickering Grant Stock Option (Right to Buy)
Feb 20, 2024 Sell 8 000 Guggenhime Andrew Stock Option (right to buy)
Feb 20, 2024 Buy 8 000 Guggenhime Andrew Common Stock
Feb 20, 2024 Sell 4 909 Guggenhime Andrew Common Stock
Feb 20, 2024 Sell 2 751 Guggenhime Andrew Common Stock
Feb 20, 2024 Sell 340 Guggenhime Andrew Common Stock
Feb 15, 2024 Buy 27 917 Wassil Jim Common Stock
Feb 15, 2024 Sell 27 917 Wassil Jim Stock Option (right to buy)
Feb 01, 2024 Sell 1 667 Eydelman Mikhail Stock Option (Right to Buy)
Feb 01, 2024 Buy 1 667 Eydelman Mikhail Common Stock
Feb 01, 2024 Sell 212 Eydelman Mikhail Common Stock
Feb 01, 2024 Sell 638 Eydelman Mikhail Common Stock
Feb 01, 2024 Sell 343 Eydelman Mikhail Common Stock
Feb 01, 2024 Sell 474 Eydelman Mikhail Common Stock
Feb 01, 2024 Buy 3 000 Wassil Jim Common Stock
Feb 01, 2024 Sell 527 Wassil Jim Common Stock
Feb 01, 2024 Sell 1 056 Wassil Jim Common Stock
Feb 01, 2024 Sell 467 Wassil Jim Common Stock
Feb 01, 2024 Sell 950 Wassil Jim Common Stock
Feb 01, 2024 Sell 3 000 Wassil Jim Stock Option (right to buy)
Feb 01, 2024 Sell 119 Pickering Grant Common Stock
Feb 01, 2024 Sell 134 Pickering Grant Common Stock
Feb 01, 2024 Sell 491 Pickering Grant Common Stock
Feb 01, 2024 Sell 655 Pickering Grant Common Stock
Feb 01, 2024 Sell 238 Pickering Grant Common Stock
Feb 01, 2024 Sell 443 Pickering Grant Common Stock
JSON CSV
INSIDER POWER
35.552
Last 100 transactions
Buy: 779 468 | Sell: 362 821 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 35.552.

In total, the insiders bought 779 468 and sold 362 821 PCVX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Vaxcyte, Inc.

Vaxcyte. Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a co... PCVX Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT